|
Volumn 59, Issue 3, 1997, Pages 171-176
|
Clarithromycin in the combination therapy for the eradication of Helicobacter pylori in peptic ulcer disease
|
Author keywords
Clarithromycin; Helicobacter pylori; Omeprazole; Peptic ulcer; Triple therapy
|
Indexed keywords
AMOXICILLIN;
BISMUTH SALICYLATE;
CIMETIDINE;
CLARITHROMYCIN;
HISTAMINE H2 RECEPTOR ANTAGONIST;
METRONIDAZOLE;
NIZATIDINE;
OMEPRAZOLE;
RANITIDINE;
ADULT;
AGED;
ARTICLE;
BACTERICIDAL ACTIVITY;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DUODENUM ULCER;
FEMALE;
GASTROINTESTINAL TOXICITY;
HELICOBACTER PYLORI;
HUMAN;
HUMAN TISSUE;
MAJOR CLINICAL STUDY;
MALE;
ORAL DRUG ADMINISTRATION;
PEPTIC ULCER;
RANDOMIZED CONTROLLED TRIAL;
RASH;
TASTE DISORDER;
ULCER HEALING;
VERTIGO;
ADULT;
AGED;
AMOXICILLIN;
ANTI-BACTERIAL AGENTS;
BISMUTH;
CLARITHROMYCIN;
DRUG THERAPY, COMBINATION;
DUODENAL ULCER;
FEMALE;
HELICOBACTER INFECTIONS;
HELICOBACTER PYLORI;
HISTAMINE H2 ANTAGONISTS;
HUMANS;
MALE;
METRONIDAZOLE;
MIDDLE AGED;
NIZATIDINE;
OMEPRAZOLE;
ORGANOMETALLIC COMPOUNDS;
PENICILLINS;
RANITIDINE;
SALICYLATES;
|
EID: 0030948645
PISSN: 05781337
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (8)
|
References (6)
|